scholarly journals Developing a decision aid to facilitate informed decision making about invasive mechanical ventilation and lung transplantation among adults with cystic fibrosis: lessons learned from usability testing (Preprint)

10.2196/21270 ◽  
2020 ◽  
Author(s):  
Katherine L. Dauber-Decker ◽  
Melissa Basile ◽  
D'Arcy King ◽  
Jennifer Polo ◽  
Karina Calise ◽  
...  
2008 ◽  
Vol 3 (4) ◽  
pp. 340-351 ◽  
Author(s):  
Jennifer D. Allen ◽  
Anshu P. Mohllajee ◽  
Rachel C. Shelton ◽  
Bettina F. Drake ◽  
Dana R. Mars

African American men experience a disproportionate burden of prostate cancer (CaP) morbidity and mortality. National screening guidelines advise men to make individualized screening decisions through a process termed informed decision making (IDM). In this pilot study, a computer-tailored decision-aid designed to promote IDM was evaluated using a pre-/posttest design. African American men aged 40 years and older were recruited from a variety of community settings ( n = 108). At pretest, 43% of men reported having made a screening decision; at posttest 47% reported this to be the case ( p = .39). Significant improvements were observed between pre- and posttest on scores of knowledge, decision self-efficacy, and decisional conflict. Men were also more likely to want an active role in decision making after using the tool. These results suggest that use of a computer-tailored decision aid is a promising strategy to promote IDM for CaP screening among African American men.


2020 ◽  
Author(s):  
Katherine L. Dauber-Decker ◽  
Melissa Basile ◽  
D'Arcy King ◽  
Jennifer Polo ◽  
Karina Calise ◽  
...  

BACKGROUND Cystic fibrosis (CF) is a life-limiting genetic disease that causes chronic lung infections. We developed an internet-based decision aid (decision aid) to help CF patients make better informed decisions regarding treatments and advance care planning (ACP). We built the decision aid around two major treatment decisions: whether or not to have a lung transplant, and whether or not to agree to intubation. OBJECTIVE To present results from iterative usability testing of the InformedChoices Cystic Fibrosis advance care planning decision aid among adults with cystic fibrosis, their clinicians and family caregivers. METHODS We performed a patient needs assessment and “think aloud” usability testing with CF patients, their surrogates, and clinicians caring for CF patients. “Think aloud” participants provided feedback while navigating the decision aid and answered surveys. Session transcripts and survey results were categorized into common, generalizable themes and optimizations for improving content, comprehension, and navigation. RESULTS Participants gave the decision aid an average System Usability Scale (SUS) score of 88.33 (“excellent”). Comments were coded into three themes: Functionality, Visibility and Navigation, and Content and Usefulness. Areas for improvement included reducing repetition, enhancing comprehension, and changing the flow. CONCLUSIONS Usability testing revealed areas for potential improvement. Testing also yielded positive feedback, suggesting the decision aid’s future success.Integrating changes prior to implementation should improve the decision aid’s comprehension, navigation, and usefulness, and lead to greater adoption.


Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Shakira Milton ◽  
Jennifer McIntosh ◽  
Finlay Macrae ◽  
Patty Chondros ◽  
Lyndal Trevena ◽  
...  

Abstract Background Australian guidelines recommend that all people aged 50–70 years old actively consider taking daily low-dose aspirin (100–300 mg per day) for 2.5 to 5 years to reduce their risk of colorectal cancer (CRC). Despite the change of national CRC prevention guidelines, there has been no active implementation of the guidelines into clinical practice. We aim to test the efficacy of a health consultation and decision aid, using a novel expected frequency tree (EFT) to present the benefits and harms of low dose aspirin prior to a general practice consultation with patients aged 50–70 years, on informed decision-making and uptake of aspirin. Methods Approximately five to seven general practices in Victoria, Australia, will be recruited to participate. Patients 50–70 years old, attending an appointment with their general practitioner (GP) for any reason, will be invited to participate in the trial. Two hundred fifty-eight eligible participants will be randomly allocated 1:1 to intervention or active control arms using a computer-generated allocation sequence stratified by general practice, sex, and mode of trial delivery (face-to-face or teletrial). There are two co-primary outcomes: informed decision-making at 1-month post randomisation, measured by the Multi-dimensional Measure of Informed Choice (MMIC), and self-reported daily use of aspirin at 6 months. Secondary outcomes include decisional conflict at 1-month and other behavioural changes to reduce CRC risk at both time points. Discussion This trial will test the efficacy of novel methods for implementing national guidelines to support informed decision-making about taking aspirin in 50–70-year-olds to reduce the risk of CRC and other chronic diseases. Trial registration The Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620001003965. Registered on 10 October 2020.


2010 ◽  
Vol 12 (2) ◽  
pp. e15 ◽  
Author(s):  
Natalie Joseph-Williams ◽  
Rhodri Evans ◽  
Adrian Edwards ◽  
Robert G Newcombe ◽  
Patricia Wright ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document